Morepen Labs FY26 BRSR: INR 1,676.66Cr Turnover With 9.39% ESG Capex Allocation
Morepen Laboratories Ltd 路 Others (Uncategorized) 路 02 Sept 2026, 6:58 pm
Morepen Labs FY26 BRSR: INR 1,676.66Cr Turnover With 9.39% ESG Capex Allocation Morepen Laboratories reported operational turnover of INR 1,676.66 crore and a net worth of INR 1,245.41 crore for the year ended 31st Mar'26. Revenue was primarily driven by the API segment (56.33%) and Medical Devices (35.60%), with exports comprising 40% of total turnover. Highlighting its ESG focus, the company allocated 9.39% of total capex towards environmental initiatives, including a 955-KW solar plant and zero-liquid-discharge systems. Furthermore, Morepen achieved an EcoVadis Bronze Medal (score 70), reinforcing its sustainability profile to support international market expansion.
Original exchange filing (PDF)
More announcements from Morepen Laboratories Ltd
- Update on Credit Rating 路 14 Nov 2026
- Please find attached the Press Release 路 09 Nov 2026
- Change in Senior Management Personnel on account of resignation 路 31 Oct 2026
- Change in Designation of Senior Management Personnel of the Company 路 28 Oct 2026
- Please find attached the monitoring agency report for the quarter ended September 30, 2026 路 27 Oct 2026
- Please find attached the Investor Presentation for Q2 & H1 FY 27 Financial Results 路 27 Oct 2026
- Please find attached the press release 路 27 Oct 2026
- Please find attached the Q2 & H1 FY 27 Financial Results 路 27 Oct 2026
